XML 28 R11.htm IDEA: XBRL DOCUMENT v3.25.4
Property Portfolio
12 Months Ended
Dec. 31, 2025
Property Portfolio  
Property Portfolio

Note 3 – Property Portfolio

Summary of Properties Acquired and Sold During the Year Ended December 31, 2025

During the year ended December 31, 2025, the Company completed the acquisition of a five-property portfolio of medical real estate. For this acquisition, substantially all of the fair value was concentrated in a single identifiable asset or group of similar identifiable assets and, therefore, this acquisition represented an asset acquisition. Accordingly, $1.0 million of transaction costs for this acquisition were capitalized.

During the year ended December 31, 2025, the Company completed seven dispositions for approximately $23.0 million, realizing an aggregate net gain of approximately $1.5 million. In addition, we recognized impairment losses on the sold assets of $13.0 million.

A rollforward of the gross investment in land, building, improvements, and acquired lease intangible assets as of December 31, 2025 is as follows:

Site

Tenant

Acquired Lease

Gross Investment in

  ​ ​

Land

  ​ ​

Building

  ​ ​

Improvements

  ​ ​

Improvements

  ​ ​

Intangible Assets

  ​ ​

Real Estate

Balances as of December 31, 2024

$

174,300

$

1,044,019

$

23,973

$

69,679

$

138,945

$

1,450,916

Facility Acquired – Date Acquired:

Carondelet - 2/7/25

13,327

1,274

1,725

16,326

Silverbell - 2/7/25

8,482

973

1,368

10,823

Slippery Rock - 2/7/25

3,511

455

593

572

5,131

Clive - 4/1/25

11,400

507

1,595

2,218

15,720

Des Moines - 4/1/25

18,917

182

3,289

3,519

25,907

Capitalized costs(1)

 

5,927

1,226

5,008

 

12,161

Total Additions:

61,564

2,370

12,732

9,402

86,068

Facility Sold – Date Sold:

Derby - 2/18/25

(146)

(1,250)

(118)

(73)

(372)

(1,959)

Coos Bay - 3/19/25

(861)

(5,096)

(56)

(49)

(410)

(6,472)

Chipley - 4/30/25

(170)

(875)

(34)

(111)

(189)

(1,379)

2999 Germantown - 8/7/25

(253)

(1,593)

(1,846)

Aurora - 9/4/25

(339)

(2,345)

(308)

(603)

(2,680)

(6,275)

Memphis Exeter - 11/4/25

(232)

(1,912)

(2,144)

Melbourne - 12/30/25

(1,200)

(8,556)

(86)

(1,178)

(123)

(11,143)

Total Dispositions:

(3,201)

(21,627)

(602)

(2,014)

(3,774)

(31,218)

Impairment of investment properties(2)

(1,182)

(11,832)

(13,014)

Balances as of December 31, 2025

$

169,917

$

1,072,124

$

25,741

$

80,397

$

144,573

$

1,492,752

(1)Represents capital projects that were completed and placed in service during the year ended December 31, 2025 related to the Company’s existing facilities.
(2)In August 2025, the Company entered into an agreement to sell its facility located in Aurora, Illinois, and recognized an impairment loss of $6.3 million to reduce the carrying value of the asset to its estimated fair value. The fair value was determined based on the contractual sales price, less commissions and fees, and the sale was completed in September 2025. In December 2025, the Company entered into an agreement to sell its facility located in Melbourne, Florida, and recognized an impairment loss of $6.7 million to reduce the carrying value of the asset to its estimated fair value. The fair value was determined based on the contractual sales price, less commissions and fees, and the sale was completed in December 2025.

Depreciation expense was $44,025, $40,427, and $41,266 for the years ended December 31, 2025, 2024, and 2023, respectively.

As of December 31, 2025, the Company had aggregate capital improvement commitments and obligations to improve, expand, and maintain the Company’s existing facilities of approximately $25.7 million. Many of these amounts are subject to contingencies that make it difficult to predict when they will be expended, if at all. In accordance with the terms of the Company’s leases, capital improvement obligations in the next twelve months are expected to total approximately $12.6 million.

Summary of Properties Acquired and Sold During the Year Ended December 31, 2024

During the year ended December 31, 2024, the Company completed the acquisition of a 15-property portfolio. For this acquisition, substantially all of the fair value was concentrated in a single identifiable asset or group of similar identifiable assets and, therefore, this acquisition represents an asset acquisition. Accordingly, transaction costs for this acquisition were capitalized.

During the year ended December 31, 2024, the Company completed seven dispositions. In June 2024, the Company sold an in-patient rehabilitation facility located in Mishawaka, Indiana receiving gross proceeds of $8.1 million, resulting in a loss of $3.4 million. In July 2024, the Company sold a medical office building located in Panama City, Florida receiving gross proceeds of $11.0 million, resulting in a gain of $1.7 million. In September 2024, the Company sold a medical office building located in Panama City Beach, Florida receiving gross proceeds of $1.1 million, resulting in a gain of $0.1 million. In December 2024, the Company sold two medical office buildings located in Carson City, Nevada receiving gross proceeds of $1.0 million, resulting in a loss of $2.4 million. In December

2024, the Company sold three medical office buildings located in Ellijay, Georgia receiving gross proceeds of $4.3 million, resulting in a gain of $0.7 million. In December 2024, in connection with the formation of the Joint Venture, the Company sold two assets to the Joint Venture consisting of a medical office building located in High Point, North Carolina receiving gross proceeds of $28.0 million resulting in gain of $6.2 million and a medical office building located in Fort Worth, Texas receiving gross proceeds of $7.2 million, resulting in a gain of $1.3 million.

A rollforward of the gross investment in land, building, improvements, and acquired lease intangible assets as of December 31, 2024 is as follows:

Site

Tenant

Acquired Lease

Gross Investment in

  ​ ​ ​

Land

  ​ ​ ​

Building

  ​ ​

Improvements

  ​ ​

Improvements

  ​ ​

Intangible Assets

  ​ ​

Real Estate

Balances as of December 31, 2023

$

164,315

$

1,035,705

$

21,974

$

66,358

$

138,617

$

1,426,969

Facility Acquired – Date Acquired:

Minot – 7/11/24

935

7,324

144

103

676

9,182

Clinton – 7/11/24

938

4,829

188

256

657

 

6,868

Westland – 7/11/24

921

3,630

157

99

540

5,347

Cerritos – 7/11/24

3,424

1,244

107

106

392

5,273

Spartanburg – 7/11/24

890

2,613

168

390

517

4,578

Conway – 10/2/24

2,430

7,415

188

372

897

11,302

Little Rock – 10/2/24

1,449

6,579

164

284

741

9,217

Russellville – 10/2/24

1,086

4,022

218

205

491

6,022

Sarasota – 10/2/24

643

4,133

548

712

6,036

Venice – 10/2/24

1,102

2,830

123

187

426

4,668

Ruskin – 10/2/24

242

1,443

28

45

175

1,933

6807 Bradenton – 10/2/24

1,225

626

22

68

180

2,121

2101 Bradenton – 10/2/24

967

1,372

52

64

235

2,690

2203 Bradenton – 10/2/24

408

913

35

37

132

1,525

6002 Bradenton – 10/2/24

1,679

2,985

112

190

463

5,429

Capitalized costs(1)

 

5,494

1,481

4,828

11,803

Total Additions:

18,339

57,452

3,187

7,782

7,234

93,994

Facility Sold – Date Sold:

Mishawaka – 6/27/24

(1,924)

(10,084)

(75)

(1,798)

(2,223)

(16,104)

Panama City – 7/12/24

(1,117)

(7,201)

(165)

(841)

(1,141)

(10,465)

Panama City Beach – 9/19/24

(272)

(606)

(21)

(84)

(149)

(1,132)

Carson City – 12/6/2024

(760)

(3,268)

(4,028)

Ellijay – 12/17/2024

(777)

(2,929)

(136)

(408)

(870)

(5,120)

High Point – 12/20/2024(2)

(1,749)

(20,417)

(504)

(869)

(1,656)

(25,195)

Fort Worth – 12/20/2024(2)

(1,487)

(3,333)

(251)

(445)

(787)

(6,303)

Total Dispositions:

(8,086)

(47,838)

(1,152)

(4,445)

(6,826)

(68,347)

Impairment of investment properties(3)

(268)

(1,300)

(36)

(16)

(80)

(1,700)

Balances as of December 31, 2024

$

174,300

$

1,044,019

$

23,973

$

69,679

$

138,945

$

1,450,916

(1)Represents capital projects that were completed and placed in service during the year ended December 31, 2024 related to the Company’s existing facilities.
(2)These two facilities were sold to the Joint Venture in connection with its formation.
(3)In December 2024, the Company entered into an agreement to sell its facility located in Derby, Kansas. The Company recognized an impairment loss of $1.7 million during the year ended December 31, 2024 to reduce the carrying value of the asset to its fair value. The fair value was determined to be the contractual sales price less commissions and fees.

Lease Intangible Assets and Liabilities

The following is a summary of the carrying amount of lease intangible assets and liabilities:

As of December 31, 2025

Accumulated

  ​ ​ ​

Cost

  ​ ​ ​

Amortization

  ​ ​ ​

Net

Assets

In-place leases

$

82,590

$

(58,294)

$

24,296

Above market leases

 

24,024

 

(15,258)

 

8,766

Leasing costs

 

37,959

 

(25,017)

 

12,942

$

144,573

$

(98,569)

$

46,004

Liability

Below market leases

$

17,335

$

(12,391)

$

4,944

As of December 31, 2024

  ​ ​ ​

  ​ ​ ​

Accumulated

  ​ ​ ​

Cost

Amortization

Net

Assets

 

  ​

 

  ​

 

  ​

In-place leases

$

77,698

$

(50,714)

$

26,984

Above market leases

 

24,599

 

(13,201)

 

11,398

Leasing costs

 

36,648

 

(21,326)

 

15,322

$

138,945

$

(85,241)

$

53,704

Liability

 

 

 

Below market leases

$

14,073

$

(10,137)

$

3,936

The following is a summary of the acquired lease intangible amortization:

Year Ended December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

Amortization expense related to in-place leases

$

9,568

$

9,942

$

11,612

Amortization expense related to leasing costs

$

4,449

$

4,544

$

5,079

Decrease in rental revenue related to above market leases

$

2,918

$

3,180

$

3,384

Increase in rental revenue related to below market leases

$

(2,271)

$

(2,009)

$

(2,332)

As of December 31, 2025, scheduled future aggregate net amortization of the acquired lease intangible assets and liabilities for each year ended December 31 is listed below:

  ​ ​ ​

  ​ ​ ​

Net Decrease

Net Increase

in Revenue

in Expense

2026

$

(477)

$

12,830

2027

 

(471)

 

9,408

2028

 

(779)

 

6,695

2029

 

(831)

 

4,196

2030

(648)

1,785

Thereafter

 

(615)

 

2,324

Total

$

(3,821)

$

37,238

For the year ended December 31, 2025, the weighted average amortization period for asset lease intangibles and liability lease intangibles are 2.8 years and 2.3 years, respectively.

Investment in Unconsolidated Joint Venture

As of December 31, 2025, the Company had one investment in an unconsolidated Joint Venture, which as of December 31, 2025 held investments in two properties located in North Carolina and Texas. The Company retains a 12.5% interest in the Joint Venture. The Company’s maximum exposure related to the Joint Venture is limited to the amount of its investment. The Joint Venture had total

debt outstanding of $17.6 million as of December 31, 2025, all of which was non-recourse to the Company. For the year ended December 31, 2025, the Company recognized a loss of $150 from its equity interest in the net loss of the Joint Venture.